Investor Relations

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases
June 23, 2022
electroCore Announces Listing Transfer to the Nasdaq Capital Market
ROCKAWAY, N.J. , June 23, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has received approval from the Nasdaq Stock Market (“Nasdaq”) to transfer the listing of its common stock from the Nasdaq
May 18, 2022
electroCore to Participate at Upcoming Investor Conferences
ROCKAWAY, N.J. , May 18, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger , will be presenting at the H.C. Wainwright Global Investment Conference and LD Micro

Investor Contact

Investor Relations

CG Capital
Rich Cockrell
404.736.3838
ECOR@cg.capital